Financial Analysis: Global Cord Blood (NYSE:CORBF) versus Viemed Healthcare (NASDAQ:VMD)

Viemed Healthcare (NASDAQ:VMDGet Free Report) and Global Cord Blood (NYSE:CORBFGet Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Profitability

This table compares Viemed Healthcare and Global Cord Blood’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.32% 9.32% 6.79%
Global Cord Blood N/A N/A N/A

Insider & Institutional Ownership

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 0.5% of Global Cord Blood shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

Viemed Healthcare has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.23, indicating that its stock price is 123% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Viemed Healthcare and Global Cord Blood, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare 0 0 0 1 4.00
Global Cord Blood 0 0 0 0 N/A

Valuation & Earnings

This table compares Viemed Healthcare and Global Cord Blood’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $183.01 million 1.49 $10.24 million $0.26 27.04
Global Cord Blood $196.12 million 0.74 $79.04 million N/A N/A

Global Cord Blood has higher revenue and earnings than Viemed Healthcare.

Summary

Viemed Healthcare beats Global Cord Blood on 8 of the 10 factors compared between the two stocks.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

About Global Cord Blood

(Get Free Report)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.